| Previous Close | 15.75 |
| Open | 15.89 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 15.58 - 15.89 |
| 52 Week Range | 14.80 - 18.18 |
| Volume | 325,430 |
| Avg. Volume | 237,896 |
| Market Cap | 575.76M |
| Beta | 0.75 |
| PE Ratio (TTM) | -22.33 |
| EPS (TTM) | -0.7 |
| Earnings Date | Oct 3, 2017 - Oct 9, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.67 |
- Accesswire•2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO
NEW YORK, NY / ACCESSWIRE / July 21, 2017 / Pomerantz LLP is investigating claims on behalf of investors of AngioDynamics, Inc. ("AngioDynamics" or the "Company") (NASDAQ: ANGO). Such ...
- Capital Cube•4 days ago
AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AngioDynamics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)
- Zacks•4 days ago
AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat
AngioDynamics (ANGO) revenues declined year over year in the fourth quarter. Recall of the Acculis product line under the oncology segment is also a concern.
